Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models.

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease primarily affecting motor neurons. Mutations in the gene encoding TDP-43 cause some forms of the disease, and cytoplasmic TDP-43 aggregates accumulate in degenerating neurons of most individuals with ALS. Thus, strategies aimed at targeting the toxicity of cytoplasmic TDP-43 aggregates may ...
be effective. Here, we report results from two genome-wide loss-of-function TDP-43 toxicity suppressor screens in yeast. The strongest suppressor of TDP-43 toxicity was deletion of DBR1, which encodes an RNA lariat debranching enzyme. We show that, in the absence of Dbr1 enzymatic activity, intronic lariats accumulate in the cytoplasm and likely act as decoys to sequester TDP-43, preventing it from interfering with essential cellular RNAs and RNA-binding proteins. Knockdown of Dbr1 in a human neuronal cell line or in primary rat neurons is also sufficient to rescue TDP-43 toxicity. Our findings provide insight into TDP-43-mediated cytotoxicity and suggest that decreasing Dbr1 activity could be a potential therapeutic approach for ALS.
Mesh Terms:
Amyotrophic Lateral Sclerosis, Animals, Cells, Cultured, Cerebral Cortex, DNA-Binding Proteins, Disease Models, Animal, Gene Deletion, Gene Knockdown Techniques, Humans, Neurons, RNA Nucleotidyltransferases, Rats, Rats, Sprague-Dawley, Saccharomyces cerevisiae, Sequence Deletion
Nat. Genet.
Date: Dec. 01, 2012
Download Curated Data For This Publication
183288
Switch View:
  • Interactions 15